A Pilot Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment
Post COVID-19 Cognitive Impairment
Enrolment: 36 · Results not recorded
Device
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Post COVID-19 Cognitive Impairment
Enrolment: 36 · Results not recorded
Opioid-use Disorder · Depression, Anxiety · Craving
Enrolment: 22 · Results not recorded
Mild to Moderate Dementia
Enrolment: 100 · Results not recorded
Autism Spectrum Disorder
Enrolment: 34 · Results not recorded
Postoperative Pain Management After Total Knee Arthroplasty
Enrolment: 68 · Results not recorded
Knee Osteoarthritis
Enrolment: 52 · Results not recorded
Chronic Pain
Enrolment: 20 · Results not recorded
Amnestic Mild Cognitive Impairment
Enrolment: 60 · Results not recorded
Dry Eye Disease · Graves Ophthalmopathy
Enrolment: 30 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Cryoinjury of the tibialis anterior muscle using a liquid nitrogen cooled metal rod of 3 mm diameter applied to the ventral muscle surface for 10 s, thawed and repeated for 10 s, then sutured
Both wavelengths reduced myonecrosis and inflammatory cell infiltration and CD68 positive M1 macrophages at day 2, while only near infrared light increased CD206 positive M2 macrophages at day 2 (p=0.0001), blood vessel numbers and immature muscle fibres at day 7 (p=0.0089).
Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.